Clinical trial
A Randomized Crossover Trial Comparing Oral Capecitabine and Intravenous Fluorouracil + Folinic Acid (Nordic FU/FA Regimen) for Patient Preference in Colorectal Cancer
NCT00212589 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Crossover Trial Comparing Oral Capecitabine and Intravenous Fluorouracil + Folinic Acid (Nordic FU/FA Regimen) for Patient Preference in Colorectal Cancer
- Lead sponsor
- Odense University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2002
- Completion date
- April 30, 2004
- Enrollment
- 60
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer